CARLYE HENLINE: Open Payments
NPI 1538574090 · THREE RIVERS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 11 payments from 9 companies in 2025. Trend: 2023 $297 · 2024 $257 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $98 |
| Novo Nordisk Inc | 3 | $65 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: DEXCOM G7 GSS (161), AIRSUPRA, Wegovy, Ozempic, GARDASIL 9, UBRELVY, Qelbree, MOUNJARO.
Industry payments across MI — which companies pay providers there.
